WA
GILD icon

WBH Advisory’s Gilead Sciences GILD Stock Holding History

WBH Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,211
Closed -$230K – 227
2017
Q4 		$230K Sell
3,211
-162
-5% -$12.3K 0.06% 207
2017
Q3 		$273K Buy
3,373
+1
+0% +$76 0.08% 193
2017
Q2 		$238K Sell
3,372
-898
-21% -$59.8K 0.07% 206
2017
Q1 		$290K Sell
4,270
-514
-11% -$36.1K 0.09% 187
2016
Q4 		$342K Sell
4,784
-848
-15% -$63K 0.11% 168
2016
Q3 		$445K Buy
+5,632
New +$458K 0.15% 139

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WBH Advisory's GILD Position: Q1 2018 in Review

WBH Advisory sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 3,211 shares — an estimated $230K sold.

WBH Advisory first reported a position in GILD in Q3 2016 and held it in 6 quarters. The position peaked at $445K in Q3 2016. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • WBH Advisory reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • WBH Advisory sold 3,211 Gilead Sciences shares in Q1 2018, an estimated $230K.
  • WBH Advisory first reported a position in Gilead Sciences in Q3 2016 and held it in 6 quarters.
  • WBH Advisory's Gilead Sciences position peaked at $445K in Q3 2016.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on WBH Advisory's 13F filing for Q1 2018, filed 30 Apr 2018.